Cartesian Therapeutics (RNAC) Goodwill & Intangibles (2023 - 2026)

Cartesian Therapeutics (RNAC) has 4 years of Goodwill & Intangibles data on file, last reported at $142.1 million in Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 28.53% year-over-year to $142.1 million in Q1 2026; TTM through Mar 2026 was $142.1 million, a 28.53% decrease from a year earlier, with the FY2025 full-year figure at $142.1 million, down 28.53% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $142.1 million, roughly flat from $142.1 million in the prior quarter.
• Over the last five years, Goodwill & Intangibles for RNAC reached as high as $198.8 million in Q4 2023 and fell as low as $142.1 million in Q4 2025.
• Historically, Goodwill & Intangibles has averaged $187.4 million across 4 years, with a median of $198.8 million in 2023.
• Across the five-year window, Goodwill & Intangibles changed 0.0% in 2024 and retreated 28.53% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $198.8 million in 2023, then changed by 0.0% to $198.8 million in 2024, then slipped by 28.53% to $142.1 million in 2025, then changed by 0.0% to $142.1 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $142.1 million in Q1 2026, $142.1 million in Q4 2025, and $198.8 million in Q3 2025.